Pleural mesothelioma malignant recurrent

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Checkpoint inhibitor (PD-1) 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting Academic
    LENVATINIB; PEMBROLIZUMAB
    2024-516618-39-00 1 country 2021 n=58
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting Academic 1 Phase II 0
New trials by year
2021
1
← All indication landscapes